These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 518456)

  • 21. The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.
    Keeton TK; Biediger AM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):350-60. PubMed ID: 3244380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of adrenergic neuron and ganglion blockers on hemodynamics and plasma catecholamine levels after corticosteroids during hemorrhagic shock in the dog.
    Haglund U; Hellman A; Häggendal E; Häggendal J; Lundberg D
    Acta Anaesthesiol Scand; 1980 Dec; 24(6):444-50. PubMed ID: 6264725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenomedullary function in the neonatal rat: responses to acute hypoxia.
    Seidler FJ; Slotkin TA
    J Physiol; 1985 Jan; 358():1-16. PubMed ID: 2858585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reflex stimulation of catecholamine secretion during the acute stage of myocardial infarction in the dog.
    Staszewska-Barczak J
    Clin Sci; 1971 Nov; 41(5):419-39. PubMed ID: 5123230
    [No Abstract]   [Full Text] [Related]  

  • 26. Paradoxical elevation of sympathetic activity during catecholamine infusion in rats.
    Johnson MD; Smith PG; Mills E; Schanberg SM
    J Pharmacol Exp Ther; 1983 Oct; 227(1):254-9. PubMed ID: 6312020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRH: cardiovascular and sympathetic modulation in brain nuclei of the rat.
    Feuerstein G; Hassen AH; Faden AI
    Peptides; 1983; 4(5):617-20. PubMed ID: 6419208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELectrophysiologic properties of bretylium tosylate on atrial myocardium.
    Mirro MJ; Webel RR; Kelly KJ; Grina LA
    J Cardiovasc Pharmacol; 1981; 3(6):1312-20. PubMed ID: 6173532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane action and catecholamine release action of bretylium tosylate in normoxic and hypoxic canine Purkinje fibers.
    Nishimura M; Watanabe Y
    J Am Coll Cardiol; 1983 Aug; 2(2):287-95. PubMed ID: 6863763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bretylium opens mucosal amiloride-sensitive sodium channels.
    Ilani A; Lichtstein D; Bacaner MB
    Biochim Biophys Acta; 1982 Dec; 693(2):503-6. PubMed ID: 6297561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of adrenergic neuron inhibitors on the vascular response to sympathetic nerve stimulation.
    Kisin I
    Pharmacology; 1976; 14(4):351-6. PubMed ID: 935248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of drugs on turnover rate of heart norepinephrine.
    Volicer L; Reid WD
    Int J Neuropharmacol; 1969 Jan; 8(1):1-7. PubMed ID: 5782993
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of the electrophysiological properties of bretylium tosylate in man].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of sympathetic nerve stimulation frequency-response relationship in rabbit ileum by guanethidine, bretylium and tetracaine.
    Kihara M; Kubo T; Misu Y
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):180-5. PubMed ID: 6667066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal medulla denervation prevents stress-induced epinephrine plasma elevation and cardiac hypertrophy.
    Womble JR; Larson DF; Copeland JG; Brown BR; Haddox MK; Russell DH
    Life Sci; 1980 Dec; 27(24):2417-20. PubMed ID: 6451781
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac arrhythmias produced by bretylium in cats anesthetized with halothane.
    Condouris GA; Ortiz J; Lyness W
    Eur J Pharmacol; 1979 Apr; 55(1):93-7. PubMed ID: 35358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
    Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The release of catechol amines by choline 2,6-XYLYL ether, bretylium and guanethidine.
    Abbs ET
    Br J Pharmacol Chemother; 1966 Jan; 26(1):162-71. PubMed ID: 5919500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.